SEC Form 4 · accession 0001562180-19-000858
Sage Therapeutics, Inc. · SAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Kanes
Officer — Chief Medical Officer
Period of report
Feb 8, 2019
Accepted (ET)
Feb 8, 2019 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 8, 2019 | S | 22,948 | $150.00 | D | 941 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2The 941 shares reported as beneficially owned were acquired by the reporting person pursuant to the issuer's employee stock purchase plan.